US$ 26.04
glp-1 vision loss drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden loss. About 6 to 10 extra cases per 10,000 users over 3 years Blurry Vision from GLP-1 Medications:
Description
GLP-1Rs: Molecular Architecture, Central Distribution, and Intracellular Signaling The GLP-1R is a class B G protein-coupled receptor (GPCR) that mediates the diverse physiological effects of GLP-1 in both peripheral and central tissues [15]
Activating GLP-1R improves the brains ability to cope with stress by influencing neurotransmitter release and pathways involved in the stress response, which may help reduce cognitive and emotional issues related to aging
I am using 250 g (thats micrograms , equivalent to 0.25 mg, a fraction of that 2.5 mg starting dose)

The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis
